BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34674862)

  • 21. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    Mack MJ; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Grayburn PA; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Rogers JH; Marx SO; Cohen DJ; Weissman NJ; Stone GW;
    J Am Coll Cardiol; 2021 Mar; 77(8):1029-1040. PubMed ID: 33632476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left Ventricular Global Longitudinal Strain as a Predictor of Outcomes in Patients with Heart Failure with Secondary Mitral Regurgitation: The COAPT Trial.
    Medvedofsky D; Milhorini Pio S; Weissman NJ; Namazi F; Delgado V; Grayburn PA; Kar S; Lim DS; Lerakis S; Zhou Z; Liu M; Alu MC; Kapadia SR; Lindenfeld J; Abraham WT; Mack MJ; Bax JJ; Stone GW; Asch FM;
    J Am Soc Echocardiogr; 2021 Sep; 34(9):955-965. PubMed ID: 33845158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial.
    Saxon JT; Cohen DJ; Chhatriwalla AK; Kotinkaduwa LN; Kar S; Lim DS; Abraham WT; Lindenfeld J; Mack MJ; Arnold SV; Stone GW
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2795-2803. PubMed ID: 33303119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.
    Grayburn PA; Sannino A; Cohen DJ; Kar S; Lim DS; Mishell JM; Whisenant BK; Rinaldi MJ; Kapadia SR; Rajagopal V; Crowley A; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Sep; 76(9):1007-1014. PubMed ID: 32854834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Halaby R; Herrmann HC; Gertz ZM; Lim S; Kar S; Lindenfeld J; Abraham WT; Grayburn PA; Naidu S; Asch FM; Weissman NJ; Zhang Y; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2021 Apr; 14(8):879-889. PubMed ID: 33888233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation.
    Malik UI; Ambrosy AP; Ku IA; Mishell JM; Kar S; Lim DS; Whisenant BK; Cohen DJ; Arnold SV; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2020 Oct; 13(20):2331-2341. PubMed ID: 33092707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: COAPT Trial.
    Kar S; Mack MJ; Lindenfeld J; Abraham WT; Asch FM; Weissman NJ; Enriquez-Sarano M; Lim DS; Mishell JM; Whisenant BK; Rogers JH; Arnold SV; Cohen DJ; Grayburn PA; Stone GW
    Circulation; 2021 Aug; 144(6):426-437. PubMed ID: 34039025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score.
    Shah N; Madhavan MV; Gray WA; Brener SJ; Ahmad Y; Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Lim DS; Mishell JM; Whisenant BK; Zhang Z; Redfors B; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2022 Oct; 15(19):1893-1905. PubMed ID: 36202557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
    Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline-Directed Medical Therapy and Survival After TEER for Secondary Mitral Regurgitation With Right Ventricular Impairment.
    Mazzola M; Giannini C; Adamo M; Stolz L; Praz F; Butter C; Pfister R; Iliadis C; Melica B; Sampaio F; Kalbacher D; Koell B; Spieker M; Metra M; Stephan von Bardeleben R; Karam N; Kresoja KP; Lurz P; Petronio AS; Hausleiter J; De Carlo M
    JACC Cardiovasc Interv; 2024 Jun; 17(12):1455-1466. PubMed ID: 38925749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum albumin and outcomes in heart failure and secondary mitral regurgitation: the COAPT trial.
    Feng KY; Ambrosy AP; Zhou Z; Li D; Kong J; Zaroff JG; Mishell JM; Ku IA; Scotti A; Coisne A; Redfors B; Mack MJ; Abraham WT; Lindenfeld J; Stone GW;
    Eur J Heart Fail; 2023 Apr; 25(4):553-561. PubMed ID: 36823954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial.
    Gertz ZM; Herrmann HC; Lim DS; Kar S; Kapadia SR; Reed GW; Puri R; Krishnaswamy A; Gersh BJ; Weissman NJ; Asch FM; Grayburn PA; Kosmidou I; Redfors B; Zhang Z; Abraham WT; Lindenfeld J; Stone GW; Mack MJ
    Circ Cardiovasc Interv; 2021 Apr; 14(4):e010300. PubMed ID: 33719505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial.
    Beohar N; Ailawadi G; Kotinkaduwa LN; Redfors B; Simonato M; Zhang Z; Morgan LG; Escolar E; Kar S; Lim DS; Mishell JM; Whisenant BK; Abraham WT; Lindenfeld J; Mack MJ; Stone GW
    Eur Heart J; 2022 May; 43(17):1639-1648. PubMed ID: 35134897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials?
    Senni M; Adamo M; Metra M; Alfieri O; Vahanian A
    Eur J Heart Fail; 2019 Jul; 21(7):852-861. PubMed ID: 31116485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Residual Mitral Regurgitation on Survival After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation.
    Higuchi S; Orban M; Stolz L; Karam N; Praz F; Kalbacher D; Ludwig S; Braun D; Näbauer M; Wild MG; Neuss M; Butter C; Kassar M; Petrescu A; Pfister R; Iliadis C; Unterhuber M; Park SD; Thiele H; Baldus S; von Bardeleben RS; Schofer N; Massberg S; Windecker S; Lurz P; Hausleiter J
    JACC Cardiovasc Interv; 2021 Jun; 14(11):1243-1253. PubMed ID: 33992551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Right Ventricular Dysfunction on Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation.
    Karam N; Stolz L; Orban M; Deseive S; Praz F; Kalbacher D; Westermann D; Braun D; Näbauer M; Neuss M; Butter C; Kassar M; Petrescu A; Pfister R; Iliadis C; Unterhuber M; Park SD; Thiele H; Baldus S; von Bardeleben RS; Blankenberg S; Massberg S; Windecker S; Lurz P; Hausleiter J
    JACC Cardiovasc Imaging; 2021 Apr; 14(4):768-778. PubMed ID: 33582067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation.
    Adamo M; Inciardi RM; Tomasoni D; Dallapellegrina L; Estévez-Loureiro R; Stolfo D; Lupi L; Pancaldi E; Popolo Rubbio A; Giannini C; Benito-González T; Fernández-Vázquez F; Caneiro-Queija B; Godino C; Munafò A; Pascual I; Avanzas P; Frea S; Boretto P; Moñivas Palomero V; Del Trigo M; Biagini E; Berardini A; Nombela-Franco L; Jimenez-Quevedo P; Lipsic E; Saia F; Petronio AS; Bedogni F; Sinagra G; Guazzi M; Voors A; Metra M
    JACC Cardiovasc Imaging; 2022 Dec; 15(12):2038-2047. PubMed ID: 36481071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial.
    Namazi F; Delgado V; Pio SM; Ajmone Marsan N; Asch FM; Medvedofsky D; Weissman NJ; Zhou Z; Redfors B; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Bax JJ
    Eur Heart J Cardiovasc Imaging; 2022 Oct; 23(11):1540-1551. PubMed ID: 36265184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.